Orencia 250 mg (Abatacept 250 mg) by Bristol Myers Squibb.
Indications: Rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriatic arthritis.
Administration: Intravenous infusion by weight band (≈10 mg/kg) at weeks 0, 2, 4, then every 4 weeks.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Bristol Myers Squibb |
| Active ingredient | Abatacept 250 mg — selective T-cell co-stimulation modulator. |
| Strength & pack | 1 vial + silicone-free disposable syringe. |
| Form | Powder for concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |